Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dow Stough, MD
Burke Pharmaceutical Research
Principal Investigator - Fran Cook-Bolden, MD
Skin Specialty Dermatology
Principal Investigator - Ian Landells, MD
Nexus Clinical Research
Principal Investigator - Kirk Barber, MD
Kirk Barber Research Inc.
Principal Investigator - Leslie Baumann, MD
Baumann Cosmetic and Research Institute
Principal Investigator - Mark Ling, MD
MedaPhase, Inc.
Principal Investigator - Michael Graeber, MD
Galderma R&D
Study Chair - Michael Heffernan, MD
Central Dermatology
Principal Investigator - Patricia Westmoreland, MD
Palmetto Clinical Trials Services, LLC
Principal Investigator - Phoebe Rich, MD
Oregon Dermatology and Research Center
Principal Investigator - Robert Haber, MD
Haber Dermatology & Cosmetic Surgery
Principal Investigator - Steven Grekin, DO
Grekin Skin Institute
Principal Investigator - Terry Jones, MD
J&S Studies Inc.
Principal Investigator - Wayne Gulliver, MD
Newlab Clinical Research Inc.
Principal Investigator - William Werschler, MD
Premier Clinical Research
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kirk Barber Research Inc.
Calgary, Alberta, Canada
- Newlab Clinical Research Inc.
St. John's, Newfoundland and Labrador, Canada
- Nexus Clinical Research
St. John's, Newfoundland and Labrador, Canada
- Burke Pharmaceutical Research
Hot Springs, Arkansas, United States
- Baumann Cosmetic and Research Institute
Miami Beach, Florida, United States
- Medaphase, Inc.
Newnan, Georgia, United States
- Dermatology Specialists Research
Louisville, Kentucky, United States
- Grekin Skin Institute
Warren, Michigan, United States
- Central Dermatology Pc
St Louis, Missouri, United States
- Skin Specialty Dermatology
New York, New York, United States
- Haber Dermatology & Cosmetic Surgery
South Euclid, Ohio, United States
- Oregon Dermatology and Research Center
Portland, Oregon, United States
- Palmetto Clinical Trial Services, Llc
Greenville, South Carolina, United States
- J&s Studies Inc.
College Station, Texas, United States
- Premier Clinical Research
Spokane, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2011
- Primary completion
- 30 Nov 2011
- Completion
- 31 Jan 2012
- Last update posted
- 18 Feb 2021
- Registered enrollment
- 293
- Registry id
- NCT01355471
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.